Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Posard Matthew L.
Apr 30 06:14
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Miyashita Akiko Moni
Apr 30 06:10
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MATSUI CONNIE
Apr 30 06:09
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Krishnan Mahesh
Apr 30 06:04
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Henderson Jeffrey William
Apr 30 05:59
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Apr 30 05:59
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Connaughton Bernadette
Apr 30 05:54
Halozyme Therapeutics | 8-K: Current report
Apr 27 04:26
Halozyme Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Krishnan Mahesh
Apr 26 04:17
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Apr 18 07:25
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 18 04:05
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 17 04:07
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Mar 27 07:40
Halozyme Therapeutics | ARS: Annual Report to Security Holders
Mar 16 04:56
Halozyme Therapeutics | DEFA14A: Others
Mar 16 04:24
Halozyme Therapeutics | DEF 14A: Definitive information statements
Mar 16 04:14
Halozyme Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaBarre Michael J.
Mar 14 05:26
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 14 04:20
Halozyme Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 13 04:14
Halozyme Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 5 05:17
No Data
No Data